Collectively, we assume that a complex interplay among multiple transcription factors, co-activators, and/or co-repressors are coordinately involved in the up-regulation of ET-1 in diabetes and its associated cardiovascular complications. This evidence concerns the gene EDN1 and diabetes mellitus.